Serveur d'exploration sur le peuplier

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Phytodolor--effects and efficacy of a herbal medicine.

Identifieur interne : 003A97 ( Main/Exploration ); précédent : 003A96; suivant : 003A98

Phytodolor--effects and efficacy of a herbal medicine.

Auteurs : Karl-Josef Gundermann [Pologne] ; Jürgen Müller

Source :

RBID : pubmed:17704984

Descripteurs français

English descriptors

Abstract

UNLABELLED

Herbal antirheumatics are successfully used in painful inflammatory or degenerative rheumatic diseases. One of these herbal medicines is Phytodolor (STW 1), a fixed combination of extracts from aspen leaves and bark (Populus tremula), common ash bark (Fraxinus excelsior), and golden rod herb (Solidago virgaurea). Its effects as well as those of its components have been verified in experimental and human pharmacological investigations. The mode of action of STW 1 includes antiinflammatory, antioedematous, antioxidative and analgesic properties, and it is considered to be broader than that of synthetic antirheumatics. Open clinical studies and randomised, placebo- or verum-controlled double-blind trials, performed in different subtypes of rheumatic diseases, confirm the pharmacological evidence of efficacy, such as by reducing the intake of non-steroidal antiinflammatory drugs (NSAIDs). STW 1 has a high drug safety.

CONCLUSION

Phytodolor (STW 1) is a reasonable alternative to NSAIDs and to cyclooxygenase(COX)-2-inhibitors such as rofecoxib.


DOI: 10.1007/s10354-007-0436-4
PubMed: 17704984


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Phytodolor--effects and efficacy of a herbal medicine.</title>
<author>
<name sortKey="Gundermann, Karl Josef" sort="Gundermann, Karl Josef" uniqKey="Gundermann K" first="Karl-Josef" last="Gundermann">Karl-Josef Gundermann</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmacology and Toxicology, Chair of Pharmacology, Pomeranian Medical Academy, Szczecin, Poland. gmc-gundermann@web.de</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, Chair of Pharmacology, Pomeranian Medical Academy, Szczecin</wicri:regionArea>
<wicri:noRegion>Szczecin</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Jurgen" sort="Muller, Jurgen" uniqKey="Muller J" first="Jürgen" last="Müller">Jürgen Müller</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17704984</idno>
<idno type="pmid">17704984</idno>
<idno type="doi">10.1007/s10354-007-0436-4</idno>
<idno type="wicri:Area/Main/Corpus">003A95</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">003A95</idno>
<idno type="wicri:Area/Main/Curation">003A95</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">003A95</idno>
<idno type="wicri:Area/Main/Exploration">003A95</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Phytodolor--effects and efficacy of a herbal medicine.</title>
<author>
<name sortKey="Gundermann, Karl Josef" sort="Gundermann, Karl Josef" uniqKey="Gundermann K" first="Karl-Josef" last="Gundermann">Karl-Josef Gundermann</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmacology and Toxicology, Chair of Pharmacology, Pomeranian Medical Academy, Szczecin, Poland. gmc-gundermann@web.de</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, Chair of Pharmacology, Pomeranian Medical Academy, Szczecin</wicri:regionArea>
<wicri:noRegion>Szczecin</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Jurgen" sort="Muller, Jurgen" uniqKey="Muller J" first="Jürgen" last="Müller">Jürgen Müller</name>
</author>
</analytic>
<series>
<title level="j">Wiener medizinische Wochenschrift (1946)</title>
<idno type="ISSN">0043-5341</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Antirheumatic Agents (administration & dosage)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Disease Models, Animal (MeSH)</term>
<term>Double-Blind Method (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Phytotherapy (MeSH)</term>
<term>Plant Extracts (administration & dosage)</term>
<term>Plant Extracts (pharmacology)</term>
<term>Plant Extracts (therapeutic use)</term>
<term>Randomized Controlled Trials as Topic (MeSH)</term>
<term>Rats (MeSH)</term>
<term>Rheumatic Diseases (drug therapy)</term>
<term>Safety (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Antirhumatismaux (administration et posologie)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Essais contrôlés randomisés comme sujet (MeSH)</term>
<term>Extraits de plantes (administration et posologie)</term>
<term>Extraits de plantes (pharmacologie)</term>
<term>Extraits de plantes (usage thérapeutique)</term>
<term>Humains (MeSH)</term>
<term>Modèles animaux de maladie humaine (MeSH)</term>
<term>Méthode en double aveugle (MeSH)</term>
<term>Phytothérapie (MeSH)</term>
<term>Rats (MeSH)</term>
<term>Rhumatismes (traitement médicamenteux)</term>
<term>Sécurité (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antirheumatic Agents</term>
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antirheumatic Agents</term>
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Antirhumatismaux</term>
<term>Extraits de plantes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Rheumatic Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Extraits de plantes</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Rhumatismes</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antirhumatismaux</term>
<term>Extraits de plantes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Disease Models, Animal</term>
<term>Double-Blind Method</term>
<term>Humans</term>
<term>Phytotherapy</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Rats</term>
<term>Safety</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Humains</term>
<term>Modèles animaux de maladie humaine</term>
<term>Méthode en double aveugle</term>
<term>Phytothérapie</term>
<term>Rats</term>
<term>Sécurité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>UNLABELLED</b>
</p>
<p>Herbal antirheumatics are successfully used in painful inflammatory or degenerative rheumatic diseases. One of these herbal medicines is Phytodolor (STW 1), a fixed combination of extracts from aspen leaves and bark (Populus tremula), common ash bark (Fraxinus excelsior), and golden rod herb (Solidago virgaurea). Its effects as well as those of its components have been verified in experimental and human pharmacological investigations. The mode of action of STW 1 includes antiinflammatory, antioedematous, antioxidative and analgesic properties, and it is considered to be broader than that of synthetic antirheumatics. Open clinical studies and randomised, placebo- or verum-controlled double-blind trials, performed in different subtypes of rheumatic diseases, confirm the pharmacological evidence of efficacy, such as by reducing the intake of non-steroidal antiinflammatory drugs (NSAIDs). STW 1 has a high drug safety.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>Phytodolor (STW 1) is a reasonable alternative to NSAIDs and to cyclooxygenase(COX)-2-inhibitors such as rofecoxib.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17704984</PMID>
<DateCompleted>
<Year>2007</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0043-5341</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>157</Volume>
<Issue>13-14</Issue>
<PubDate>
<Year>2007</Year>
</PubDate>
</JournalIssue>
<Title>Wiener medizinische Wochenschrift (1946)</Title>
<ISOAbbreviation>Wien Med Wochenschr</ISOAbbreviation>
</Journal>
<ArticleTitle>Phytodolor--effects and efficacy of a herbal medicine.</ArticleTitle>
<Pagination>
<MedlinePgn>343-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="UNLABELLED">Herbal antirheumatics are successfully used in painful inflammatory or degenerative rheumatic diseases. One of these herbal medicines is Phytodolor (STW 1), a fixed combination of extracts from aspen leaves and bark (Populus tremula), common ash bark (Fraxinus excelsior), and golden rod herb (Solidago virgaurea). Its effects as well as those of its components have been verified in experimental and human pharmacological investigations. The mode of action of STW 1 includes antiinflammatory, antioedematous, antioxidative and analgesic properties, and it is considered to be broader than that of synthetic antirheumatics. Open clinical studies and randomised, placebo- or verum-controlled double-blind trials, performed in different subtypes of rheumatic diseases, confirm the pharmacological evidence of efficacy, such as by reducing the intake of non-steroidal antiinflammatory drugs (NSAIDs). STW 1 has a high drug safety.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Phytodolor (STW 1) is a reasonable alternative to NSAIDs and to cyclooxygenase(COX)-2-inhibitors such as rofecoxib.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gundermann</LastName>
<ForeName>Karl-Josef</ForeName>
<Initials>KJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Toxicology, Chair of Pharmacology, Pomeranian Medical Academy, Szczecin, Poland. gmc-gundermann@web.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Müller</LastName>
<ForeName>Jürgen</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Austria</Country>
<MedlineTA>Wien Med Wochenschr</MedlineTA>
<NlmUniqueID>8708475</NlmUniqueID>
<ISSNLinking>0043-5341</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>141444-11-3</RegistryNumber>
<NameOfSubstance UI="C092917">Phytodolor N</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008517" MajorTopicYN="Y">Phytotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012216" MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>28</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2007</Year>
<Month>01</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2007</Year>
<Month>05</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>8</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>8</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17704984</ArticleId>
<ArticleId IdType="doi">10.1007/s10354-007-0436-4</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Semin Arthritis Rheum. 2005 Jun;34(6):773-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15942912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Z Naturforsch C. 1998 Mar-Apr;53(3-4):233-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9687162</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arzneimittelforschung. 1995 Feb;45(2):174-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7710443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arzneimittelforschung. 1995 Feb;45(2):172-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7710442</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arzneimittelforschung. 2000 Apr;50(4):362-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10800635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Z Naturforsch C. 1998 Mar-Apr;53(3-4):241-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9687163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arzneimittelforschung. 1996 Aug;46(8):809-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9125284</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 1999 Sep 21;131(6):409-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10498556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheum Dis Clin North Am. 2000 Feb;26(1):13-27, vii</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10680191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Fortschr Med. 1991 Apr 10;109(11):248-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1855751</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Pologne</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Muller, Jurgen" sort="Muller, Jurgen" uniqKey="Muller J" first="Jürgen" last="Müller">Jürgen Müller</name>
</noCountry>
<country name="Pologne">
<noRegion>
<name sortKey="Gundermann, Karl Josef" sort="Gundermann, Karl Josef" uniqKey="Gundermann K" first="Karl-Josef" last="Gundermann">Karl-Josef Gundermann</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A97 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:17704984
   |texte=   Phytodolor--effects and efficacy of a herbal medicine.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:17704984" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020